Fluoroquinolones for systemic or inhaled use (OFLOXACIN EURO, LEVOFLOXACIN EURO) – reminder of restrictions on use (risk of long-lasting serious adverse reactions)

11.10.2023 1189 views

Фторхінолони для системного або інгаляційного застосування (ОФЛОКСАЦИН ЄВРО, ЛЕВОФЛОКСАЦИН ЄВРО) – нагадування про обмеження застосування (ризик виникнення тривалих серйозних побічних реакцій)PDF · 484 КБ

Завантажити

Fluoroquinolones for systemic or inhaled use (OFLOXACIN EURO, LEVOFLOXACIN EURO) – reminder of restrictions on use (risk of long-lasting serious adverse reactions)

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Fluoroquinolones for systemic or inhaled use (OFLOXACIN EURO, LEVOFLOXACIN EURO) – reminder of restrictions on use (risk of long-lasting serious adverse reactions)

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration